Recent Developments in Pharmacovigilance at UMC
Author:
- Sten OlssonSOSten Olsson
- 1 January 2018
- book chapter
- Published by Elsevier
- p. 435-442
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Pharmacovigilance in resource-limited countriesExpert Review of Clinical Pharmacology, 2015
- Using VigiBase to Identify Substandard Medicines: Detection Capacity and Key PrerequisitesDrug Safety, 2015
- Teaching Pharmacovigilance: the WHO-ISoP Core Elements of a Comprehensive Modular CurriculumDrug Safety, 2014
- Improved Statistical Signal Detection in Pharmacovigilance by Combining Multiple Strength-of-Evidence Aspects in vigiRankDrug Safety, 2014
- Adverse Drug Reaction Reporting by Patients: An Overview of Fifty CountriesDrug Safety, 2014
- Performance of Probabilistic Method to Detect Duplicate Individual Case Safety ReportsDrug Safety, 2014
- vigiGrade: A Tool to Identify Well-Documented Individual Case Reports and Highlight Systematic Data Quality IssuesDrug Safety, 2013
- WHO Strategy for Collecting Safety Data in Public Health Programmes: Complementing Spontaneous Reporting SystemsDrug Safety, 2013
- Safety surveillance of longitudinal databases: methodological considerationsPharmacoepidemiology and Drug Safety, 2011
- Earlier discovery of pregabalin’s dependence potential might have been possibleEuropean Journal of Clinical Pharmacology, 2010